Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
Clinical Efficacy of alpha 1-blocker Naftopidil in Patients with Overactive Bladder Associated with Benign Prostatic Hyperplasia
LUTS: Lower Urinary Tract Symptoms, 07/23/09
Kakizaki H et al. – Naftopidil improves not only voiding symptoms, but also storage symptoms associated with BPH, and is effective for improving bladder storage function in patients with detrusor overactivity.
Related Articles
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
Cochrane Reviews, 10/20/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Fluoxetine Blocks Myotonic Runs and Reverts Abnormal Surface Electromyogram Pattern in Patients With Myotonic Dystrophy Type 1
Clinical Neuropharmacology, 12/16/09
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
Pharmacology & Therapeutics, 12/16/09
Use of over-the-counter analgesics and perceived stress among 25-44-year olds
Pharmacoepidemiology and Drug Safety, 12/16/09
Today in Men`s Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia
World Journal of Urology, 12/16/09
The Effect of Perceived Racial Discrimination on Bodily Pain among Older African American Men
Pain Medicine, 12/15/09
Male breast cancer: A population-based comparison with female breast cancer
Journal of Clinical Oncology, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


